QATCH Technologies is a life-science instrumentation start-up, founded in 2016 to commercialize a sensor technology developed at Duke University. The company is currently focused on developing a tool to prescreen injectability and manufacturability of biopharmaceutical drugs at an early stage of drug development, due to the very low volume needed (μLs). QATCH's proprietary technology is designed to de-risk the preclinical phase for biopharmaceutical drug development and prevent delays for crucial medicines reaching patients. Its core industries include Biotechnology, Life Sciences, and Pharmaceuticals.
The most recent investment in QATCH Technologies, amounting to $250.00K, was a Debt Financing round that occurred on 08 June 2023. The investment came from the North Carolina Biotechnology Center, signifying confidence in the company's innovative approach and potential within the life sciences and biotechnology sectors.
